CONCORDANCE OF NON-INVASIVE TESTS FOR LIVER FIBROSIS IN HCV PATIENTS PROPOSED FOR TREATMENT WITH DIRECT ACTING ANTIVIRALS

CONCORDANCE OF NON-INVASIVE TESTS FOR LIVER FIBROSIS IN HCV PATIENTS PROPOSED FOR TREATMENT WITH DIRECT ACTING ANTIVIRALS

With the introduction of direct acting antivirals in the therapeutic armamentarium of hepatitis C (HCV), policy makers have set criteria for treatment eligibility. In Romania, the combination of ombitasvir/paritaprevir/ritonavir and dasabuvir is reimbursed for F4 fibrosis on liver biopsy/Fibromax,...

Full description

Bibliographic Details
Main Authors: Andreea Cazan, Catalin Dutei, Ioana Husar-Sburlan, Vasile Balaban, Maria Ispas, Mihaela Barbu, Oana Balas, Boroka Horeanga, Denisa Oprisanescu, Mircea Diculescu, Emanoil Ceausu, Petre Iacob Calistru, Mircea Manuc
Format: Article
Language:English
Published: Amaltea Medical Publishing House 2018-09-01
Series:Romanian Journal of Infectious Diseases
Subjects:
chronic hcv infection
liver fibrosis
direct acting antivirals
Online Access:https://revistemedicale.amaltea.ro/Romanian_Journal_of_INFECTIOUS_DISEASES/Revista_Romana_de_BOLI_INFECTIOASE-2018-Nr.3/RJID_2018_3_EN_Art-05.pdf

Internet

https://revistemedicale.amaltea.ro/Romanian_Journal_of_INFECTIOUS_DISEASES/Revista_Romana_de_BOLI_INFECTIOASE-2018-Nr.3/RJID_2018_3_EN_Art-05.pdf

Similar Items